0 -(4-methyl-1,3-thiazol-5-yl)-2-oxo-2,3,2 0 0 0 ,3 0 0 0 ,5 0 0 0 ,6 0 0 0 ,7 0 0 0 ,7a 0 0 0 -octahydro-1Hindole-3-spiro-3'-1H-pyrrolizin-2 0 0 0 -yl]prop-2-en-1-one
N-(Quinuclidin-3-yl)-2-(1-methyl-1H-indol-3-yl)-2-oxo-acetamide: a high affinity 5-HT3 receptor partial agonist
✍ Scribed by R.D. Clark; J.M. Muchowski; K.K. Weinhardt; M.P. Dillon; C-H. Lee; K.R. Bley; D.W. Bonhaus; E.H.F. Wong; R.M. Eglen
- Book ID
- 103983030
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 195 KB
- Volume
- 5
- Category
- Article
- ISSN
- 0960-894X
No coin nor oath required. For personal study only.
✦ Synopsis
The enantiomers of the indolyl-2-oxoacetamide 5 were found to have 5-HT3 receptor partial agonist activity with (R)-5 having higher potency than (S)-5.
📜 SIMILAR VOLUMES
## Abstract For Abstract see ChemInform Abstract in Full Text.
The molecular structure of the title compound, C~39~H~62~N~2~O~5~Si~2~, obtained as an unexpected side product, was determined in the course of our studies on the synthesis of __N__-triisopropyl-1__H__-indol-3-yl derivatives. Interestingly, although the triisopropylsilyl group was intended as a temp
## Abstract For Abstract see ChemInform Abstract in Full Text.